|
|
Volumn 73, Issue 3, 2013, Pages 1046-1049
|
|
Twenty-fourth annual pezcoller symposium: Molecular basis for resistance to targeted agents
a
b
c
c
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABIRATERONE;
B RAF KINASE;
B RAF KINASE INHIBITOR;
BCR ABL PROTEIN;
BOSUTINIB;
CABAZITAXEL;
CETUXIMAB;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY;
DABRAFENIB;
DANUSERTIB;
ENZALUTAMIDE;
ERLOTINIB;
EVEROLIMUS;
EXEMESTANE;
GEFITINIB;
IMATINIB;
INSULIN RECEPTOR SUBSTRATE 1;
INSULIN RECEPTOR SUBSTRATE 2;
INTERLEUKIN 2;
MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;
NILOTINIB;
OLAPARIB;
PANITUMUMAB;
PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;
PLACEBO;
PLATINUM COMPLEX;
PROTEIN KINASE B;
PROTEIN KINASE B INHIBITOR;
UNINDEXED DRUG;
VEMURAFENIB;
ADVANCED CANCER;
B RAF KINASE GENE;
BLOOD ANALYSIS;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RESEARCH;
CANCER RESISTANCE;
CANCER SURVIVAL;
CELL SURVIVAL;
CHRONIC MYELOID LEUKEMIA;
CLINICAL EFFECTIVENESS;
COLORECTAL CANCER;
CONFERENCE PAPER;
DRUG EFFECT;
DRUG EFFICACY;
DRUG RESPONSE;
EPITHELIAL MESENCHYMAL TRANSITION;
GENE MUTATION;
GENETIC ASSOCIATION;
GENOME ANALYSIS;
GENOMIC INSTABILITY;
HUMAN;
LIQUID BIOPSY;
LUNG CANCER;
LUNG SMALL CELL CANCER;
MEDULLOBLASTOMA;
MELANOMA;
METASTASIS;
MOLECULAR DYNAMICS;
MOLECULARLY TARGETED THERAPY;
NONHUMAN;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROTEIN DEGRADATION;
PROTEIN PHOSPHORYLATION;
SIGNAL TRANSDUCTION;
TUMOR GENE;
BREAST NEOPLASMS;
COLORECTAL NEOPLASMS;
DRUG RESISTANCE, NEOPLASM;
EPITHELIAL-MESENCHYMAL TRANSITION;
FEMALE;
HUMANS;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
MALE;
MELANOMA;
MUTATION;
NEOPLASMS;
PROSTATIC NEOPLASMS;
PROTO-ONCOGENE PROTEINS B-RAF;
TUMOR MICROENVIRONMENT;
|
|
EID: 84873481449
PISSN: 00085472
EISSN: 15387445
Source Type: Journal
DOI: 10.1158/0008-5472.CAN-12-3236 Document Type: Conference Paper |
|
Times cited : (7)
|
|
References (0)
|
